Startup Funding

Showing 660 articles
Business

AbCellera Biologics: A Valuation Crossroads After Volatile Returns

Shares of antibody discovery firm AbCellera Biologics (ABCL) present a complex picture for investors, with strong one-year gains overshadowed by steep declines over longer horizons. As the stock trades near $3.86, a significant gap emerges between its market price and some analyst fair value estimates, raising questions about its premium valuation in a challenging biotech market.

Business

IBM Kicks Off 2026 Tech Bond Rush with Multi-Billion Dollar Offering

IBM has launched a multi-billion dollar, multi-currency bond sale, becoming one of the first major technology firms to access debt markets this year. The move, which comes amid strong investor appetite for tech credit, is seen as a bellwether for how the sector will fund growth initiatives in artificial intelligence and strategic acquisitions.